The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Diabcare Asia 2001 - Korea : Country Report on Outcome Data and Analysis

Rhee, Sang-Youl;Kim, Young-Seol;Oh, Seung-Joon;Choi, Woong-Hwan;Park, Jong-Eun;Jeong, Woo-Jin

  • Published : 20050300
⟨ Previous Next ⟩

Abstract

Background : The Diabcare-Asia study was designed for the purpose of describing diabetes control and management, and late complication status in the diabetic population. Methods : From the $1^{st}$ of July 2001 to the $1^{st}$ of September 2001, data from 1170 diabetic patients were collected in 21 centers (one university hospital and 20 clinics located in Seoul and in Gyeonggi, Korea), and blood samples were collected for centralized HbA1c measurements. Results : Only 16.8% of patients at the clinics reported self-monitoring their blood glucose. The mean $HbA_{1c}$ was 7.3 $\pm$ 1.4% at the hospital and 7.5 $\pm$ 1.5% at the clinics, and the mean fasting plasma glucose (FPG) levels were 7.0 $\pm$ 3.3 mmol/L at the hospital and 7.9 $\pm$ 2.5 mmol/L at the clinics. About 40% of patients had a $HbA_{1c}$ and FPG above the normal upper limits. Screening for microalbuminuria was rarely performed. The available data represents only about 0.9% of the patients at the hospital and 12.3% of the patients at the clinics. Nephropathy (serum creatinine >2 mg/dL) was found in 0.8% of the patients at the hospital and in 3.4% of the patients at the clinics. Retinopathy and neuropathy were commonly reported diabetic complications. The prevalence of other severe late complications was relatively low. Conclusion : The data revealed suboptimal glycemic control in about 40% of patients.

Keywords

References

  1. King H, Aubert RE, Herman WH, Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998 https://doi.org/10.2337/diacare.21.9.1414
  2. Cockram CS. The epidemiology of diabetes mellitus in the AsiaPacific region. Hong Kong Med J 6:43-52, 2000
  3. Park Y, Lee H, Koh CS, Min H, Yoo K, Kim Y, Shin Y, Prevalence of diabetes and IGT in yonchon county, South Korea. Diabeles Care 18:545-548, 1995
  4. Kim YI, Choi CS, Kim SW, Lee JS, Kim HH, Lee MS, Lee SI, Park JY, Hong SK, Lee KU, Prevalence of diabetes mellitus and impaired glucose tolerance in Korean adults living in Jungup district, South Korea. J Korean Diabetes Assoc 22:363-371, 1998
  5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993 https://doi.org/10.1056/NEJM199309303291401
  6. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the diabetes control and complications trial (DCCT). Diabetologia 41:416-423, 1998 https://doi.org/10.1007/s001250050924
  7. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 47:1703-1720, 1995 https://doi.org/10.1038/ki.1995.236
  8. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998 https://doi.org/10.1016/S0140-6736(98)07019-6
  9. UK Prospective Diabetes Study Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998 https://doi.org/10.1016/S0140-6736(98)07037-8
  10. Nitiyanant W, Tandhanand S, Mahtab H, Zhu XX, Pan CY, Raheja BS, Sathe SR, Soegondo S, Soewondo P, Kim YS, Embong M, Lantion-Ano L, Lim-Abraham MA, Lee WW, Wijesuriya M, Tai TY, Chuang LM, Le HL, Cockram C, Jorgensen LN, Yeo JP, The Dlabcare-Asia 1998 study: outcomes on control and complications in type 1 and type 2 diabetic patients. Curr Med Res Opin 18:317-327, 2002 https://doi.org/10.1185/030079902125000822
  11. Chuang LM, Tsal ST, Huang BY, Tai TY. The status of diabetes control in Asia: a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998. Diabet Med 19:978-985, 2002 https://doi.org/10.1046/j.1464-5491.2002.00833.x
  12. The Asia-Pacific Perspective. Redefining obesity and its treatment. Health Communications Australia Pty. 2000
  13. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 25:213-229, 2002 https://doi.org/10.2337/diacare.25.1.213
  14. European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med 16:716-730, 1999 https://doi.org/10.1046/j.1464-5491.1999.00166.x
  15. Type 2 diabetes practical targets and treatments, 3rd ed. Health Communications Australia Pty Limited, 2002
  16. Harris MI. Health care and health status and outcomes for patients With type 2 diabetes. Diabetes Care 23:754-758, 2000 https://doi.org/10.2337/diacare.23.6.754